Medical Device | Healthcare | Biotechnology | Pharmaceuticals

The global  glycobiology market  is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Glycobiology is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycobiology products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. Glycobiology Market Dynamics Drivers Increasing funding for proteomics & glycomics research and growing R&D expenditure Growth of the proteomics market Technological advancements in glycomics instrumentation Restraints High degree of consolidation acts as an entry barrier for new entrants Stringent regulatory frameworks and time-consuming approval processes Opportunities Increased use of personalized medicine Biomarkers identification Developing countries and emerging ma...

Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycomics products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The global  glycobiology market  is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market. Glycobiology is a promising approach to biomarker discovery and validation. The development of various separation techniques coupled with the advanced structure determination capabilities of this field makes possible the separation and identification of thousands of glycans...